| Accession Number: | 0001225208-19-007862 |
| Date: | 2019-05-09 |
| Issuer: | EDWARDS LIFESCIENCES CORP (EW) |
| Original Submission Date: |
VALERIANI NICHOLAS J
ONE EDWARDS WAY
IRVINE, CA 92614
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2019-05-09 | A | 1,323 | a | $0.00 | 9,995 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | these restricted stock units were granted on may 9, 2019 under the edwards lifesciences corporation nonemployee directors stock incentive program. they are scheduled to become 100% vested after the earlier of one year from the grant date or issuer's next annual meeting of stockholders. the underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on issuer's board. |
